143 related articles for article (PubMed ID: 6285697)
1. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.
Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN
Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies.
Hasholt L; Wandall A; Sørensen SA
Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353
[TBL] [Abstract][Full Text] [Related]
3. ConA-mediated binding and uptake of purified alpha-galactosidase A in Fabry fibroblasts.
Hasholt L; Sørensen SA
Exp Cell Res; 1983 Oct; 148(2):405-11. PubMed ID: 6313412
[TBL] [Abstract][Full Text] [Related]
4. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
[TBL] [Abstract][Full Text] [Related]
5. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
Osada T; Kuroda Y; Ikai A
Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.
Lemansky P; Bishop DF; Desnick RJ; Hasilik A; von Figura K
J Biol Chem; 1987 Feb; 262(5):2062-5. PubMed ID: 3029062
[TBL] [Abstract][Full Text] [Related]
7. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote.
Osada T; Kuroda Y; Ikai A
Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088
[TBL] [Abstract][Full Text] [Related]
8.
Kytidou K; Beekwilder J; Artola M; van Meel E; Wilbers RHP; Moolenaar GF; Goosen N; Ferraz MJ; Katzy R; Voskamp P; Florea BI; Hokke CH; Overkleeft HS; Schots A; Bosch D; Pannu N; Aerts JMFG
J Biol Chem; 2018 Jun; 293(26):10042-10058. PubMed ID: 29674318
[TBL] [Abstract][Full Text] [Related]
9. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
Sifers RN; Mayes JS; Nordquist RE
Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.
Marchesan D; Cox TM; Deegan PB
J Inherit Metab Dis; 2012 Nov; 35(6):1107-17. PubMed ID: 22450713
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
Johnson DL; Desnick RJ
Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
[No Abstract] [Full Text] [Related]
12. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies.
Hasholt L; Sørensen SA
Clin Chim Acta; 1984 Sep; 142(2):257-61. PubMed ID: 6094040
[No Abstract] [Full Text] [Related]
13. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
Fensom AH; Benson PF; Grant AR; Jacobs L
J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
[TBL] [Abstract][Full Text] [Related]
14. Residual activity of alpha-galactosidase A in Fabry's disease.
Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
[TBL] [Abstract][Full Text] [Related]
15. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer.
Ziegler RJ; Yew NS; Li C; Cherry M; Berthelette P; Romanczuk H; Ioannou YA; Zeidner KM; Desnick RJ; Cheng SH
Hum Gene Ther; 1999 Jul; 10(10):1667-82. PubMed ID: 10428212
[TBL] [Abstract][Full Text] [Related]
16. Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.
Fuller M; Mellett N; Hein LK; Brooks DA; Meikle PJ
Mol Genet Metab; 2015 Feb; 114(2):268-73. PubMed ID: 25468650
[TBL] [Abstract][Full Text] [Related]
17. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.
Ishii S; Chang HH; Kawasaki K; Yasuda K; Wu HL; Garman SC; Fan JQ
Biochem J; 2007 Sep; 406(2):285-95. PubMed ID: 17555407
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of human alpha-galactosidase A expressed in insect cells using a baculovirus vector.
Chen Y; Jin M; Goodrich L; Smith G; Coppola G; Calhoun DH
Protein Expr Purif; 2000 Nov; 20(2):228-36. PubMed ID: 11049747
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes.
Wandall A; Hasholt L; Sørensen SA
Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349
[TBL] [Abstract][Full Text] [Related]
20. Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery.
Sakuraba H; Chiba Y; Kotani M; Kawashima I; Ohsawa M; Tajima Y; Takaoka Y; Jigami Y; Takahashi H; Hirai Y; Shimada T; Hashimoto Y; Ishii K; Kobayashi T; Watabe K; Fukushige T; Kanzaki T
J Hum Genet; 2006; 51(4):341-352. PubMed ID: 16532254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
